Drugs / High Dose Fluzone®
last change Jan 2011 re-read 2 minutes ago

High Dose Fluzone®

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · Stanford University

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03022396 Sep 2010 → Jan 2011 influenza Stanford University Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as High Dose Fluzone ClinicalTrials.gov intervention name — accepted as the source's own label NCT03022396
Modality Vaccine “Licensed seasonal High dose trivalent inactivated influenza” NCT03022396
Route Intramuscular “High Dose Fluzone® (intramuscular)” NCT03022396